Implantation or Injectable Dosage Form New Animal Drugs; Sarafloxacin Hydrochloride

摘要

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Abbott Laboratories. The NADA provides for use of sarafloxacin hydrochloride solution for injection in day-old broiler chickens for control of early mortality associated with Escherichia coli organisms susceptable to sarafloxacin.